The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK. As an executive agency of the Department of Health and Social Care, the MHRA ensures medical products meet rigorous standards of safety, quality and efficacy. The agency manages clinical trial applications, marketing authorisations and surveillance through the Yellow Card scheme. This work protects millions who depend on safe healthcare products. By combining scientific expertise with risk-proportionate regulation, the MHRA enables early access to innovative treatments while maintaining vigilant oversight, serving patients, healthcare professionals and industry at national and international levels.
1553
Team Members
2003
Founded
NHS
Sector
Hybrid
Work Environment
A world where patients have the earliest possible access to safe, effective medicines and medical devices, supported by regulatory science that defines international standards and protects public health globally.
At MHRA, our mission is to use scientific expertise, support for innovation and the risk-proportionate regulation of medical products, to protect and improve public health across the UK.